
Needham has decided to maintain its Buy rating of Pacira BioSciences (NASDAQ:PCRX) and lower its price target from $84.00 to $76.00.
Shares of Pacira BioSciences are trading up 3.85% over the last 24 hours, at $53.47 per share.

Needham has decided to maintain its Buy rating of Pacira BioSciences (NASDAQ:PCRX) and lower its price target from $84.00 to $76.00.
Shares of Pacira BioSciences are trading up 3.85% over the last 24 hours, at $53.47 per share.